Respiratory Infections clinical trials

Explore recruiting respiratory infections clinical trials.

Recruiting respiratory infections studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Respiratory Infections trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Multicenter, Adaptive, Randomized, Controlled Trial Platform to Evaluate Safety and Efficacy of Strategies and Treatments for Hospitalized Patients with Respiratory Infections: Strategies and Treatments for Respiratory Infections & Viral Emergencies (STRIVE) - Shionogi Protease Inhibitor (S-217622)

Spain, Germany, Greece, Denmark, Poland, Ireland

Therapeutic confirmatory (Phase III) EU CTIS Study details

OM85 in the prevention of respiratory infections in elderly patients at risk

Italy

Therapeutic use (Phase IV) EU CTIS Study details

A Multicenter, Adaptive, Randomized, Controlled Trial Platform to Evaluate Safety and Efficacy of Strategies and Treatments for Hospitalized Patients with Respiratory Infections: Strategies and Treatments for Respiratory Infections & Viral Emergencies (STRIVE) - Immune Modulation Strategy Trial

Denmark, France, Sweden, Spain, Ireland, Germany +3 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

COPD-2VAX: Enhancing Protection Against Respiratory Infections Through AS01-Mediated Innate Immune Activation in High-Risk Patients

Denmark

Therapeutic use (Phase IV) EU CTIS Study details

A randomized double-blind placebo-controlled study to demonstrate the efficacy of PMBL® sublingual tablets in reducing the incidence of respiratory tract infections in children aged 3-12 years (PIRTIK).

Poland

Therapeutic use (Phase IV) EU CTIS Study details

A single-dose, open-label, randomized, two-period, two-sequence, crossover pivotal bioequivalence study on 400 mg / 5 mL amoxicillin + 57 mg / 5 mL of clavulanic acid powder for oral suspension in healthy volunteers under fed conditions.

Czechia

Human Pharmacology (Phase I)- Bioequivalence Study EU CTIS Study details

Respiratory Infections trials by city

Respiratory Infections in Toronto Respiratory Infections in Vancouver Respiratory Infections in Montreal Respiratory Infections in Calgary Respiratory Infections in Edmonton Respiratory Infections in Ottawa Respiratory Infections in Winnipeg Respiratory Infections in Quebec City Respiratory Infections in Hamilton Respiratory Infections in Kitchener Respiratory Infections in London Respiratory Infections in Halifax Respiratory Infections in New York Respiratory Infections in Los Angeles Respiratory Infections in Chicago Respiratory Infections in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease